After success of the first meeting in Paris, we are pleased to welcome you to the 2nd International Conference on Sublobar resections for lung cancer that will take place in NewYork City on the 26th and 27th of September, 2019.
The treatment of early-stage lung cancer is rapidly evolving. Recently, we have progressively moved from pulmonary lobectomies – considered until recently as the gold standard – to novel treatments including stereotactic radiotherapy, ablation and sublobar resections. At a time where lung screening programs are identifying earlier tumors, the management of ground glass opacities, early stage cancers, and metastatic nodules will become a major issue for thoracic oncologists and surgeons.
By nature, thoracic surgeons are convinced that surgical resection offers the best option in terms of pathological diagnosis, tumor staging and survival. But surgeons are also aware they must reduce the morbidity of their procedures while continuing to become less invasive.
This explains the recent interest in sublobar resections. This group of interested surgeons continues to innovate and advance techniques while enhancing knowledge and methods for sublobar resection. As this evolution arises at a time when thoracoscopic and robotic techniques are also spreading and developing, most surgeons agree that when pulmonary segmentectomies are done, the technique should be performed without opening the chest. However, performing a thoracoscopic anatomic segmentectomy poses unique technical problems and is challenging.
It is this challenge and the great interest in this topic during the first conference that has encouraged us to organize this 2nd international conference by popular demand. The meeting plans to rotate from Europe to America to Asia in a constant cycle.
We are looking forward to welcoming you in New York.
The Organizing Committee